Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

著者: Paolo G. Casali, Stefan Bielack, N. Abecassis, Hannu T. Aro, Sebastian Bauer, R. Biagini, Sylvie Bonvalot, I. Boukovinas, Judith V.M.G. Bovée, Bernadette Brennan, Thomas Brodowicz, J.M. Broto, Laurence Brugières, Angela Buonadonna, E. De Álava, Angelo Paolo Dei Tos, Xavier García del Muro, Palma Dileo, Catharina Dhooge, Mikael Eriksson, Franca Fagioli, Alexander N. Fedenko, Virginia Ferraresi, Andrea Ferrari, Stefano Ferrari, Anna Maria Frezza, Nathalie Gaspar, Silvia Gasperoni, Hans Gelderblom, Thierry Gil, Giovanni Grignani, Alessandro Gronchi, Rick L. Haas, A. Bassim Hassan, Stefanie Hecker‐Nolting, Peter Hohenberger, Rolf D. Issels, Heikki Joensuu, Robin L. Jones, Ian Judson, Paul C. Jutte, Suzanne E. J. Kaal, Leo Kager, Bernd Kasper, Kateřina Kopečková, Dagmar Adámková Krákorová, Ruth Ladenstein, Axel Le Cesne, Iwona Ługowska, Ofer Merimsky, Michael Montemurro, Bruce Morland, Maria A. Pantaleo, Raimondo Piana, Piero Picci, Sophie Piperno‐Neumann, A.L. Pousa, Peter Reichardt, Martin Robinson, Piotr Rutkowski, Akmal Safwat, Patrick Schöffski, Stefan Sleijfer, Silvia Stacchiotti, Sandra J. Strauss, Kirsten Sundby Hall, Mojca Unk, Frits van Coevorden, Winette T.A. van der Graaf, Jeremy Whelan, Eva Wardelmann, Olga Zaikova, Jean‐Yves Blay - Annals of Oncology 2018 被引用: 641

Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database [1]. Different bone tumour subtypes have distinct patterns of incidence, and each has no more than 0.3 incident cases per 100 000 per year. Osteosarcoma (OS) and Ewing sarcoma (ES) have a relatively high incidence in the second decade of life, whereas chondrosarcoma (CS) is more common in older age [2–4].